Teuza

Venture Capital Active Haifa, Israel Est. 1991
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
10
in our dataset
Rounds participated
13
Rounds led
2
Rounds' value
$20.5M
total disclosed, rounds participated
Stages
B Round, Seed, A Round, D Round, E Round, C Round, F Round, G Round

About

Teuza is a pioneering fund in the Israeli venture capital industry. The firm invests in a variety of sectors, including medical devices, healthcare, biotechnology, telecommunications, semiconductors, and software. Teuza invests in all stages, from seed to start-up and through later-stage growth. The fund believes in taking a hands-on approach to assisting its portfolio companies, including involvement in the ongoing management through board membership; active participation in setting strategy and tactics; recruitment of key positions; and involvement in funding, budget decisions, and more. The funds policy is to connect its portfolio companies with strategic partners from its broad business network, typically well-known multinational companies that bring added value. Teuzas stock is traded on the Tel Aviv Stock Exchange. Teuza was founded in 1992. The companys largest current shareholder is American entrepreneur Alfred Mann, with a 22% holding. In April 2018, Teuza was chosen to manage a new $27.9 million tech fund sponsored by the Israeli city of Haifa. The new fund will invest in early-stage start-ups willing to commit to establishing their operations in Haifa.

Portfolio · 10

EndoCure
EndoCure is transforming an off-the-shelf ultrasound into an AI-enabled, objective, high-res 3D tool
1 round $400K committed Latest: 2024-05
GyneCheck
Remote Female Care
1 round Latest: 2024-01
Valid.it Evaluation Solutions
AI-powered Validation of User-provided Information for Online Processes at Scale
2 rounds $425K committed Latest: 2023-04
PV Nano Cell
Single-crystal Conductive Nano Inks
1 round $3.0M committed Latest: 2022-10
Sealantis
Alga-mimetic Tissue Adhesives
Led ★ 1 round Latest: 2016-11
DigiFlex
Inkjet-based Computer-to-Plate Printing Technology
3 rounds $7.7M committed Latest: 2013-04
TytoCare
Remote Primary Care and a Home Smart Clinic
1 round $1.5M committed Latest: 2012-07
Advanced Dicing Technologies
Semiconductor Wafer Dicing Equipment
Led ★ 1 round Latest: 2010-01
Oramir Semiconductor Equipment
Laser Cleaning Technologies for Semiconductor Wafers
1 round $7.5M committed Latest: 1997-01
Bioness
Neuromuscular Electrical Stimulation Systems
1 round

Investment activity

6 portfolio exits on record.

Portfolio by sector

Industrial Technologies5
Health Tech & Life Sciences5
Fintech & Insurtech1
Energy Tech1

Q&A

What are Teuza's most recent investments?
In January 2024, Teuza invested in EndoCure's Pre-Seed round, which raised $2.55M. In May 2024, Teuza also participated in a Seed round for GyneCheck.
What is Teuza's sector focus for investments?
Teuza primarily focuses on Industrial Technologies and Health Tech & Life Sciences, with 5 portfolio companies in each sector. They also have investments in Fintech & Insurtech and Energy Tech.
Can you provide details on Teuza's recent exits?
Teuza had an exit in March 2021 with the acquisition of Bioness by Bioventus for $110M. Prior to that, in July 2020, Sage Design Automation was acquired by Applied Materials for $30M.
What is Teuza's investment stage preference?
Teuza invests across all stages, from Seed to later-stage growth, including Pre-Seed, Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
Which portfolio companies has Teuza recently added?
Teuza added EndoCure to its portfolio in January 2024 and GyneCheck in May 2024.
What is Teuza's approach to assisting its portfolio companies?
Teuza takes a hands-on approach, including involvement in ongoing management through board membership, active participation in setting strategy and tactics, recruitment of key positions, and involvement in funding and budget decisions.
Where is Teuza headquartered?
Teuza is headquartered in Haifa, Israel.
What is Teuza's history and market presence?
Teuza was founded in 1992 and is a pioneering fund in the Israeli venture capital industry. Its stock is traded on the Tel Aviv Stock Exchange.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)